Načítá se...
Hemorrhagic pericarditis associated with rivaroxaban in an atrial fibrillation patient with pacemaker
Rivaroxaban is a new oral anticoagulant used for the prevention of stroke in patients with atrial fibrillation. Hemorrhagic pericarditis is known to occur with rivaroxaban; however, only a few case reports in the literature describe such events. Recently, we experienced hemorrhagic pericarditis that...
Uloženo v:
| Vydáno v: | Transl Clin Pharmacol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Korean Society for Clinical Pharmacology and Therapeutics
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7033380/ https://ncbi.nlm.nih.gov/pubmed/32095464 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12793/tcp.2017.25.3.138 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|